Page 3 - இடைக்கால தகவல்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

1 / of 2 COVID-19 vaccine from China s Sinovac 91.25 per cent effective, Turkey says after trial involving 7,000 volunteers Posted ThuThursday 24 DecDecember 2020 at 11:03pm CoronaVac vaccine, made by Sinovac, is currently on phase 3 clinical trials at Acibadem Hospital in Istanbul. ( Print text only Cancel A COVID-19 vaccine developed by China s Sinovac Biotech has been 91.25 per cent effective, according to interim data from a late-stage trial in Turkey, a potentially much better result than reported from a separate trial of the vaccine in Brazil. Key points: Common adverse effects caused by the vaccine were fever, mild pain and slight fatigue 26 of the 29 people who were infected during the trial were given placebos

United statesUnited kingdomIftihar koksalFahrettin kocaHealth ministrySinovac biotechHealth minister fahrettin kocaCovid 19Interim dataCorona virusஒன்றுபட்டது மாநிலங்களில்ஒன்றுபட்டது கிஂக்டம்ஆரோக்கியம் அமைச்சகம்இடைக்கால தகவல்கள்கொரோனா வைரஸ்